The Global Non-Invasive Prenatal Testing market size is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research.

Despite NIPT being accessible in growing amounts of regions, there is a major commercial push expected to assist consumer expansion in the projected years. NIPT was confirmed through similarities with standard prenatal aneuploidy screening and found to be a beneficial screening procedure with keen sensitivity and specificity.

With the increasing occurrence of pregnancy and complications, non-invasive prenatal testing is expected to become a routine procedure in the future, replacing other, riskier screening procedures.

The extensive analysis covered in the report offers insights into the estimated growth of the market during the forecast timeline. The report estimates the CAGR at which the market is expected to grow throughout the forecast timeline of 2020-2028.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/16

For the purpose of this report, Emergen Research has segmented into the global Non-Invasive Prenatal Testing market based on the method, end-use, application, and region:

• Method Outlook (Revenue, USD Billion; 2017-2027)
  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-free DNA in Maternal Plasma Tests
  • Others
• End-Use Outlook (Revenue, USD Billion; 2017-2027)
  • Diagnostic Laboratories
  • Hospitals
  • Research Centers
  • Clinics
• Application Outlook (Revenue, USD Billion; 2017-2027)
  • Trisomy
  • Microdeletion Syndrome
  • Others

Some Key Highlights From the Report

• Based on the method, ultrasound detection generated a revenue of USD 0.86 billion in 2019 and believed to rise with a CAGR of 14.0% in the forecast period, owing to the ability of the ultrasound diagnosis to detect anomalies in the position of the baby and actions within the womb.
• The hospital segment expected to grow with a CAGR of 14.1% in the forecasted period due to the growing introduction of non-invasive prenatal testing coupled with rapid technological developments and groundbreaking acceptance strategies.
• The trisomy application is the major contributor to the Non-Invasive Prenatal Testing Market. The trisomy application of the North America region is the major shareholder of the market and held around 45.1% of the market in the year 2019, owing to the high incidence of genetic disorders correlated with trisomy’s, such as Patau syndrome, Down syndrome, and Edward syndrome.

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

Radical Highlights of the Non-Invasive Prenatal Testing Market Report:

• Study of the latest product launches and technological advancements to help the readers in formulating investment strategies
• Focus on market scenario, dynamics, and trends to be expected in the coming years
• Advanced analytical tools such as Porter’s Five Forces analysis, SWOT analysis, feasibility analysis, and investment return analysis
• Thorough regional analysis to offer insights into production and consumption patterns, supply and demand ratio, market size, revenue contrition, and the presence of prominent players
• Competitive landscape benchmarking with a focus on business profiles, product portfolio, business strategies such as MA activities, revenue, market positions, market share, global position, and financial standing
• Accurate 8-year forecast analysis for the growth of Non-Invasive Prenatal Testing market
• Extensive analysis of market drivers, restraints, growth prospects, opportunities, threats, and limitations

Regional Analysis of the Non-Invasive Prenatal Testing Market includes:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

North America dominated the market for Non-Invasive Prenatal Testing in 2019 due to the availability of technologically advanced healthcare research system, the region's production of WGS. The North America region held approximately 48.8% of the market, followed by Europe, which contains around 25.4% market in the year 2019.

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/16  

Thank you for reading our report. The report can be customized according to the clients’ requirements. Please get in touch with us to know more about the report, and our team will ensure the report is well suited to your requirements.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:                   

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756